J. Garland

Mr. J.
S.
Garland is an Independent Director at Olema Pharmaceuticals, Inc., an Independent Director at ALX Oncology Holdings, Inc. and an Independent Director at Day One Biopharmaceuticals, Inc. He is on the Board of Directors at Olema Pharmaceuticals, Inc., ALX Oncology Holdings, Inc. and Day One Biopharmaceuticals, Inc. Mr. Garland was previously employed as a Chief Executive Officer & Director by PACT Pharma, Inc., an Independent Director by Calithera Biosciences, Inc., a President, Chief Executive Officer & Director by Portola Pharmaceuticals LLC, an Independent Director by Karyopharm Therapeutics, Inc., a President by Relypsa, Inc., a Chief Commercial Officer by Exelixis, Inc., a Vice President-Avastin Franchise by Genentech, Inc., and a Head-Sales & Marketing Division by Amgen, Inc. He received his undergraduate degree from California Polytechnic State University (San Luis Obispo) and an MBA from The Fuqua School of Business.